March 15, 2025
Headlines

Celltrion receives U.S. FDA approval for STOBOCLO ® (denosumab-bmwo) and OSENVELT ® (denosumab-bmwo) biosimilars referencing PROLIA ® and XGEVA ®

admin01 mins


Celltrion receives approval from the US FDA for Stoboclo® (Denosumab-Bmwo) and Osenvelt® (Denosumab-BMWO) , #Celltrion #receives #U.S #FDA #approval #STOBOCLO #denosumabbmwo #OSENVELT #denosumabbmwo #biosimilars #referencing #PROLIA #XGEVA

Leave a Reply

Your email address will not be published. Required fields are marked *

Related News